Moreover, recent studies suggest that Netrin-1 may become a therapeutic target in the treatment of various pathologies, either as a stimulant or inhibitor of angiogenesis such as in diabetes or cancer, respectively, even protecting the heart against ischemia-reperfusion injury [2, 40, 41]. The gene discussed is NTN1; the disease is cancer.